Restatement of Previously Issued Financial Statements - Schedule of Cash Flows (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Cash flows from operating activities:
Net loss	$ (81,393)	$ (69,804)	$ (62,789)	$ 18,930	$ (151,197)	$ (43,859)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization					31,995	12,250
Stock-based compensation expense					6,968	11,145
Noncash research and development expense (finance lease)					0	434
Noncash operating lease expense					11,908	14,966
Gain from sale of priority review voucher	0		0		0	(92,930)
Excess inventory reserve					5,666	6,278
Other non-cash items					(21)	343
Gain on foreign currency exchange rates					(581)	(281)
Changes in operating assets and liabilities:
Prepaid expenses and other assets					(35,131)	(6,440)
Inventory					(15,729)	(17,599)
Operating right of use assets						0
Accounts payable					12,517	(5,623)
Accrued expenses and other liabilities					(5,670)	3,052
Accrued interest payable under finance lease					5,646	819
Operating lease liabilities					(8,303)	(13,276)
Deferred revenue					0	(138)
Net cash (used in) provided by operating activities					(140,928)	(130,859)
Cash flows from investing activities:
Purchase of property, plant and equipment					(1,834)	(937)
Purchases of marketable securities					0	(34,418)
Proceeds from maturities of marketable securities					0	26,521
Proceeds from sales of marketable securities					0	5,853
Purchase of intangible assets					0	(868)
Proceeds from sale of priority review voucher					0	92,930
Net cash provided by investing activities					966	89,081
Cash flows from financing activities:
Proceeds from exercise of stock options and ESPP contributions					0	85
Principal payments on finance leases					(48,645)	(28,504)
Net cash provided by financing activities					58,584	101,507
Increase in cash, cash equivalents and restricted cash					(81,378)	59,729
Cash, cash equivalents and restricted cash at beginning of period		$ 274,597		158,445	274,597	158,445
Cash, cash equivalents and restricted cash at end of period	193,219		218,174		193,219	218,174
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents	144,067		172,872		144,067	172,872	$ 221,755
Restricted cash included in other current assets	1,154		1,364		1,154	1,364
Restricted cash included in restricted cash and other non-current assets	47,998		43,938		47,998	43,938
Total cash, cash equivalents and restricted cash	$ 193,219		218,174		193,219	218,174	$ 274,597
Supplemental cash flow disclosures from investing and financing activities:
Right-of-use assets obtained in exchange for operating lease liabilities						0
Increase (Reduction) of right of use asset and associated operating lease liability due to lease reassessment						0
Purchases of property, plant and equipment included in accounts payable and accrued expenses					284	2,290
Right-of-use assets obtained in exchange for financial lease liabilities					43,055	3,436
Cash paid (refund received) during the period for income taxes						7
As Previously Reported
Cash flows from operating activities:
Net loss			(72,908)	21,240		(51,668)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization						2,052
Stock-based compensation expense						11,145
Noncash research and development expense (finance lease)						0
Noncash operating lease expense						0
Gain from sale of priority review voucher						(92,930)
Excess inventory reserve						3,939
Other non-cash items						343
Gain on foreign currency exchange rates						0
Changes in operating assets and liabilities:
Prepaid expenses and other assets						(9,082)
Inventory						(16,496)
Operating right of use assets						24,102
Accounts payable						(14,767)
Accrued expenses and other liabilities						3,625
Accrued interest payable under finance lease						0
Operating lease liabilities						(19,488)
Deferred revenue						(138)
Net cash (used in) provided by operating activities						(159,363)
Cash flows from investing activities:
Purchase of property, plant and equipment						(937)
Purchases of marketable securities						(34,418)
Proceeds from maturities of marketable securities						26,521
Proceeds from sales of marketable securities						5,853
Purchase of intangible assets						(868)
Proceeds from sale of priority review voucher						92,930
Net cash provided by investing activities						89,081
Cash flows from financing activities:
Proceeds from exercise of stock options and ESPP contributions						85
Principal payments on finance leases						0
Net cash provided by financing activities						130,011
Increase in cash, cash equivalents and restricted cash						59,729
Cash, cash equivalents and restricted cash at beginning of period				158,445		158,445
Cash, cash equivalents and restricted cash at end of period			218,174			218,174
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents			172,872			172,872
Restricted cash included in other current assets			1,364			1,364
Restricted cash included in restricted cash and other non-current assets			43,938			43,938
Total cash, cash equivalents and restricted cash			218,174			218,174
Supplemental cash flow disclosures from investing and financing activities:
Right-of-use assets obtained in exchange for operating lease liabilities						44,968
Increase (Reduction) of right of use asset and associated operating lease liability due to lease reassessment						(14)
Purchases of property, plant and equipment included in accounts payable and accrued expenses						2,290
Right-of-use assets obtained in exchange for financial lease liabilities						0
Cash paid (refund received) during the period for income taxes						7
Revision of Prior Period, Error Correction, Adjustment | Adjustments to Embedded Leases
Cash flows from operating activities:
Net loss			9,482	(2,351)		7,131
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization						10,274
Stock-based compensation expense						0
Noncash research and development expense (finance lease)						434
Noncash operating lease expense						14,966
Gain from sale of priority review voucher						0
Excess inventory reserve						0
Other non-cash items						0
Gain on foreign currency exchange rates						(281)
Changes in operating assets and liabilities:
Prepaid expenses and other assets						2,642
Inventory						1,838
Operating right of use assets						(24,102)
Accounts payable						9,144
Accrued expenses and other liabilities						(573)
Accrued interest payable under finance lease						819
Operating lease liabilities						6,212
Deferred revenue						0
Net cash (used in) provided by operating activities						28,504
Cash flows from investing activities:
Purchase of property, plant and equipment						0
Purchases of marketable securities						0
Proceeds from maturities of marketable securities						0
Proceeds from sales of marketable securities						0
Purchase of intangible assets						0
Proceeds from sale of priority review voucher						0
Net cash provided by investing activities						0
Cash flows from financing activities:
Proceeds from exercise of stock options and ESPP contributions						0
Principal payments on finance leases						(28,504)
Net cash provided by financing activities						(28,504)
Increase in cash, cash equivalents and restricted cash						0
Cash, cash equivalents and restricted cash at beginning of period				0		0
Cash, cash equivalents and restricted cash at end of period			0			0
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents			0			0
Restricted cash included in other current assets			0			0
Restricted cash included in restricted cash and other non-current assets			0			0
Total cash, cash equivalents and restricted cash			0			0
Supplemental cash flow disclosures from investing and financing activities:
Right-of-use assets obtained in exchange for operating lease liabilities						(44,968)
Increase (Reduction) of right of use asset and associated operating lease liability due to lease reassessment						14
Purchases of property, plant and equipment included in accounts payable and accrued expenses						0
Right-of-use assets obtained in exchange for financial lease liabilities						3,436
Revision of Prior Period, Error Correction, Adjustment | Other Adjustments
Cash flows from operating activities:
Net loss			637	41		678
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization						(76)
Stock-based compensation expense						0
Noncash research and development expense (finance lease)						0
Noncash operating lease expense						0
Gain from sale of priority review voucher						0
Excess inventory reserve						2,339
Other non-cash items						0
Gain on foreign currency exchange rates						0
Changes in operating assets and liabilities:
Prepaid expenses and other assets						0
Inventory						(2,941)
Operating right of use assets						0
Accounts payable						0
Accrued expenses and other liabilities						0
Accrued interest payable under finance lease						0
Operating lease liabilities						0
Deferred revenue						0
Net cash (used in) provided by operating activities						0
Cash flows from investing activities:
Purchase of property, plant and equipment						0
Purchases of marketable securities						0
Proceeds from maturities of marketable securities						0
Proceeds from sales of marketable securities						0
Purchase of intangible assets						0
Proceeds from sale of priority review voucher						0
Net cash provided by investing activities						0
Cash flows from financing activities:
Proceeds from exercise of stock options and ESPP contributions						0
Principal payments on finance leases						0
Net cash provided by financing activities						0
Increase in cash, cash equivalents and restricted cash						0
Cash, cash equivalents and restricted cash at beginning of period				$ 0		0
Cash, cash equivalents and restricted cash at end of period			0			0
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents			0			0
Restricted cash included in other current assets			0			0
Restricted cash included in restricted cash and other non-current assets			0			0
Total cash, cash equivalents and restricted cash			$ 0			0
Supplemental cash flow disclosures from investing and financing activities:
Right-of-use assets obtained in exchange for operating lease liabilities						0
Increase (Reduction) of right of use asset and associated operating lease liability due to lease reassessment						0
Purchases of property, plant and equipment included in accounts payable and accrued expenses						0
Right-of-use assets obtained in exchange for financial lease liabilities						0
Cash paid (refund received) during the period for income taxes						0
Revision of Prior Period, Error Correction, Adjustment | Error Correction, Leases
Supplemental cash flow disclosures from investing and financing activities:
Cash paid (refund received) during the period for income taxes						0
Private Placement
Cash flows from financing activities:
Proceeds from issuance of common stock					0	(196)
Private Placement | As Previously Reported
Cash flows from financing activities:
Proceeds from issuance of common stock						(196)
Private Placement | Revision of Prior Period, Error Correction, Adjustment | Adjustments to Embedded Leases
Cash flows from financing activities:
Proceeds from issuance of common stock						0
Private Placement | Revision of Prior Period, Error Correction, Adjustment | Other Adjustments
Cash flows from financing activities:
Proceeds from issuance of common stock						0
Public Offering
Cash flows from financing activities:
Proceeds from issuance of common stock					$ 0	130,122
Public Offering | As Previously Reported
Cash flows from financing activities:
Proceeds from issuance of common stock						130,122
Public Offering | Revision of Prior Period, Error Correction, Adjustment | Adjustments to Embedded Leases
Cash flows from financing activities:
Proceeds from issuance of common stock						0
Public Offering | Revision of Prior Period, Error Correction, Adjustment | Other Adjustments
Cash flows from financing activities:
Proceeds from issuance of common stock						$ 0